G Leonardi Selected Research

G Leonardi Research Topics

Disease

2	Infections 04/2016 - 04/2003
2	Nephrolithiasis 04/2011 - 11/2009
1	Myofascial Pain Syndromes (Myofascial Pain Syndrome) 11/2023
1	Humeral Fractures 07/2022
1	Osteoporosis 07/2022
1	Multiple Fractures 07/2022
1	Low Back Pain (Lumbago) 10/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2016
1	Brain Neoplasms (Brain Tumor) 04/2016
1	Breast Neoplasms (Breast Cancer) 04/2016
1	Merkel Cell Carcinoma 04/2016
1	Temporal Lobe Epilepsy 04/2016
1	Glioma (Gliomas) 04/2016
1	Tuberculosis (Tuberculoses) 04/2016
1	Parathyroid Neoplasms (Parathyroid Neoplasm) 04/2016
1	Neoplasms (Cancer) 04/2016
1	Prostatic Neoplasms (Prostate Cancer) 04/2016
1	Thyroid Neoplasms (Thyroid Cancer) 04/2016
1	Multiple Myeloma 04/2016
1	Hepatocellular Carcinoma (Hepatoma) 01/2014
1	Poisoning 03/2011
1	Necrosis 09/2009
1	Microcephaly 07/2006
1	Epilepsy (Aura) 07/2006
1	Periventricular Nodular Heterotopia 07/2006
1	Vasculitis (Vasculitides) 12/2004
1	Lupus Nephritis 12/2004
1	Hemolytic-Uremic Syndrome 12/2004
1	Thrombotic Thrombocytopenic Purpura 12/2004
1	Brain Death (Brain Dead) 04/2004
1	Cytokine Release Syndrome 04/2004
1	Fibrosis (Cirrhosis) 03/2004
1	Persistent Infection 04/2003

Drug/Important Bio-Agent (IBA)

2	SolutionsIBA 07/2022 - 04/2016
2	melamineIBA 04/2011 - 11/2009
2	CreatinineIBA 12/2004 - 04/2003
1	Botulinum Toxins (Botulinum Toxin)IBA 11/2023
1	TitaniumIBA 07/2022
1	ElementsIBA 07/2022
1	OzoneIBA 10/2021
1	Oxygen (Dioxygen)IBA 10/2021
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 04/2016
1	AcidsIBA 04/2016
1	AerosolsIBA 04/2016
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2016
1	Choline (Choline Chloride)IBA 04/2016
1	Ciprofloxacin (Cipro)FDA LinkGeneric 04/2016
1	Dictyostelium severin protein (severin)IBA 04/2016
1	Yttrium-90IBA 04/2016
1	Dihydroxyphenylalanine (Dopa)IBA 04/2016
1	Verapamil (Calan)FDA LinkGeneric 04/2016
1	N,N'- bis(2- hydroxy- 5- (ethylene- beta- carboxy)benzyl)ethylenediamine N,N'-diacetic acidIBA 04/2016
1	multidrug resistance-associated protein 1IBA 04/2016
1	fluorocholineIBA 04/2016
1	fluoromethylcholineIBA 04/2016
1	5-(2-fluoroethyl) 2,4- diethyl- 3- (ethylsulfanylcarbonyl)- 6- phenylpyridine- 5- carboxylateIBA 04/2016
1	radium Ra 223 dichlorideIBA 04/2016
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 04/2016
1	lipoarabinomannan (LAM)IBA 04/2016
1	ErbB Receptors (EGF Receptor)IBA 04/2016
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 04/2016
1	melanin-concentrating hormone receptorIBA 04/2016
1	23-seleno-25-homotaurocholic acidIBA 04/2016
1	Liposomes (Liposome)IBA 04/2016
1	Methionine (L-Methionine)FDA Link 04/2016
1	gallium 68 PSMA-11IBA 04/2016
1	Everolimus FDA Link 01/2014
1	Sorafenib (BAY 43-9006)FDA Link 01/2014
1	Carbon MonoxideIBA 03/2011
1	Biomarkers (Surrogate Marker)IBA 11/2009
1	Dipyridamole (Persantine)FDA LinkGeneric 09/2009
1	ADP-Ribosylation Factors (ADP-Ribosylation Factor)IBA 07/2006
1	Guanine NucleotidesIBA 07/2006
1	FilaminsIBA 07/2006
1	thiamine triphosphorate (TTP)IBA 12/2004
1	DNA (Deoxyribonucleic Acid)IBA 04/2003
1	Viral DNAIBA 04/2003
1	Intravenous Immunoglobulins (IVIG)FDA Link 04/2003

Therapy/Procedure

4	Therapeutics 10/2021 - 04/2003
1	Intramuscular Injections 11/2023
1	Liver Transplantation 01/2014
1	Nephrectomy 04/2004
1	Transplantation 04/2003